The influence of masticatory hypofunction on developing rat craniofacial structure

C. Y. Tsai, L. Y. Yang, K. T. Chen, W. C. Chiu

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The purpose of this study was to use botulinum neurotoxin type A (BoNT/A) selectively to evaluate the influence of localized masticatory atrophy and paresis on craniofacial growth and development. 60 growing rats, 4 weeks old, weighing approximately 120 g, were randomly divided according as follows (Long-Evans, N = 15 per group): I (Mb + Tns); II (Mns + Tb); III (Mb + Tb); IV (Mns + Tns), where Mb or Tb is the BoNT/A-injected masseter or temporalis muscles (1.0 U/muscle, 2.5 ml) and Mns or Tns is the saline-injected muscles (2.5 ml). After 7 weeks, the mature rats were killed, the muscles dissected and mean muscle mass recorded. Anthropometric cranial, maxillary and mandibular measurements were taken from the dried skulls. Changes in animal weight during the growth period were not statistically significant. The mean masticatory muscle mass was smaller for the BoNT/A-injected muscles of Mb and Tb. Anthropometric measurements of bony structures inserted by masseter and temporalis muscles revealed a significant treatment effect. The measurements showed a facial morphology typical of a dolichofacial profile: short upper face accompanied by a long lower face with an extended mandibular length and ramus height and constricted bicoronoidal and bigonial widths. The results suggest that induction of localized masticatory muscle atrophy with BoNT/A alters craniofacial growth and development.

Original languageEnglish
Pages (from-to)593-598
Number of pages6
JournalInternational Journal of Oral and Maxillofacial Surgery
Volume39
Issue number6
DOIs
Publication statusPublished - Jun 2010

Fingerprint

Type A Botulinum Toxins
Muscles
Masticatory Muscles
Growth and Development
Masseter Muscle
Muscular Atrophy
Paresis
Skull
Atrophy
Weights and Measures
Growth

Keywords

  • botulinum neurotoxin
  • craniofacial growth and development
  • masseter muscle
  • masticatory muscle atrophy
  • temporalis muscle

ASJC Scopus subject areas

  • Oral Surgery
  • Otorhinolaryngology
  • Surgery
  • Medicine(all)

Cite this

The influence of masticatory hypofunction on developing rat craniofacial structure. / Tsai, C. Y.; Yang, L. Y.; Chen, K. T.; Chiu, W. C.

In: International Journal of Oral and Maxillofacial Surgery, Vol. 39, No. 6, 06.2010, p. 593-598.

Research output: Contribution to journalArticle

Tsai, C. Y. ; Yang, L. Y. ; Chen, K. T. ; Chiu, W. C. / The influence of masticatory hypofunction on developing rat craniofacial structure. In: International Journal of Oral and Maxillofacial Surgery. 2010 ; Vol. 39, No. 6. pp. 593-598.
@article{3487aabdec224d588f77e1bde1809c45,
title = "The influence of masticatory hypofunction on developing rat craniofacial structure",
abstract = "The purpose of this study was to use botulinum neurotoxin type A (BoNT/A) selectively to evaluate the influence of localized masticatory atrophy and paresis on craniofacial growth and development. 60 growing rats, 4 weeks old, weighing approximately 120 g, were randomly divided according as follows (Long-Evans, N = 15 per group): I (Mb + Tns); II (Mns + Tb); III (Mb + Tb); IV (Mns + Tns), where Mb or Tb is the BoNT/A-injected masseter or temporalis muscles (1.0 U/muscle, 2.5 ml) and Mns or Tns is the saline-injected muscles (2.5 ml). After 7 weeks, the mature rats were killed, the muscles dissected and mean muscle mass recorded. Anthropometric cranial, maxillary and mandibular measurements were taken from the dried skulls. Changes in animal weight during the growth period were not statistically significant. The mean masticatory muscle mass was smaller for the BoNT/A-injected muscles of Mb and Tb. Anthropometric measurements of bony structures inserted by masseter and temporalis muscles revealed a significant treatment effect. The measurements showed a facial morphology typical of a dolichofacial profile: short upper face accompanied by a long lower face with an extended mandibular length and ramus height and constricted bicoronoidal and bigonial widths. The results suggest that induction of localized masticatory muscle atrophy with BoNT/A alters craniofacial growth and development.",
keywords = "botulinum neurotoxin, craniofacial growth and development, masseter muscle, masticatory muscle atrophy, temporalis muscle",
author = "Tsai, {C. Y.} and Yang, {L. Y.} and Chen, {K. T.} and Chiu, {W. C.}",
year = "2010",
month = "6",
doi = "10.1016/j.ijom.2010.02.011",
language = "English",
volume = "39",
pages = "593--598",
journal = "International Journal of Oral and Maxillofacial Surgery",
issn = "0901-5027",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - The influence of masticatory hypofunction on developing rat craniofacial structure

AU - Tsai, C. Y.

AU - Yang, L. Y.

AU - Chen, K. T.

AU - Chiu, W. C.

PY - 2010/6

Y1 - 2010/6

N2 - The purpose of this study was to use botulinum neurotoxin type A (BoNT/A) selectively to evaluate the influence of localized masticatory atrophy and paresis on craniofacial growth and development. 60 growing rats, 4 weeks old, weighing approximately 120 g, were randomly divided according as follows (Long-Evans, N = 15 per group): I (Mb + Tns); II (Mns + Tb); III (Mb + Tb); IV (Mns + Tns), where Mb or Tb is the BoNT/A-injected masseter or temporalis muscles (1.0 U/muscle, 2.5 ml) and Mns or Tns is the saline-injected muscles (2.5 ml). After 7 weeks, the mature rats were killed, the muscles dissected and mean muscle mass recorded. Anthropometric cranial, maxillary and mandibular measurements were taken from the dried skulls. Changes in animal weight during the growth period were not statistically significant. The mean masticatory muscle mass was smaller for the BoNT/A-injected muscles of Mb and Tb. Anthropometric measurements of bony structures inserted by masseter and temporalis muscles revealed a significant treatment effect. The measurements showed a facial morphology typical of a dolichofacial profile: short upper face accompanied by a long lower face with an extended mandibular length and ramus height and constricted bicoronoidal and bigonial widths. The results suggest that induction of localized masticatory muscle atrophy with BoNT/A alters craniofacial growth and development.

AB - The purpose of this study was to use botulinum neurotoxin type A (BoNT/A) selectively to evaluate the influence of localized masticatory atrophy and paresis on craniofacial growth and development. 60 growing rats, 4 weeks old, weighing approximately 120 g, were randomly divided according as follows (Long-Evans, N = 15 per group): I (Mb + Tns); II (Mns + Tb); III (Mb + Tb); IV (Mns + Tns), where Mb or Tb is the BoNT/A-injected masseter or temporalis muscles (1.0 U/muscle, 2.5 ml) and Mns or Tns is the saline-injected muscles (2.5 ml). After 7 weeks, the mature rats were killed, the muscles dissected and mean muscle mass recorded. Anthropometric cranial, maxillary and mandibular measurements were taken from the dried skulls. Changes in animal weight during the growth period were not statistically significant. The mean masticatory muscle mass was smaller for the BoNT/A-injected muscles of Mb and Tb. Anthropometric measurements of bony structures inserted by masseter and temporalis muscles revealed a significant treatment effect. The measurements showed a facial morphology typical of a dolichofacial profile: short upper face accompanied by a long lower face with an extended mandibular length and ramus height and constricted bicoronoidal and bigonial widths. The results suggest that induction of localized masticatory muscle atrophy with BoNT/A alters craniofacial growth and development.

KW - botulinum neurotoxin

KW - craniofacial growth and development

KW - masseter muscle

KW - masticatory muscle atrophy

KW - temporalis muscle

UR - http://www.scopus.com/inward/record.url?scp=77953287480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953287480&partnerID=8YFLogxK

U2 - 10.1016/j.ijom.2010.02.011

DO - 10.1016/j.ijom.2010.02.011

M3 - Article

C2 - 20219321

AN - SCOPUS:77953287480

VL - 39

SP - 593

EP - 598

JO - International Journal of Oral and Maxillofacial Surgery

JF - International Journal of Oral and Maxillofacial Surgery

SN - 0901-5027

IS - 6

ER -